H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019
The Protecting Consumer Access to Generic Drugs Act (H.R. 1499) would remove barriers that have prevented lower-cost generic medications from getting in the hands of older Americans by banning the use of pay-for-delay agreements that provide financial benefits to drug manufacturers at the expense of consumers.
The Congressional Budget Office estimates that H.R. 1499 would reduce federal spending by $520 million and increase revenues by $93 million over the next decade.